bims-auttor Biomed News
on Autophagy and mTOR
Issue of 2026–11–22
27 papers selected by
Viktor Korolchuk, Newcastle University



  1. Methods Mol Biol. 2027 ;3104 169-180
      The physiological importance of mitochondrial quality control has been uncovered by the finding that genes for early-onset Parkinson's disease (PD), PINK1 and Parkin, regulate mitochondrial autophagy, called mitophagy, and motility. Dopaminergic neurons derived from human induced pluripotent stem (iPS) cells are a useful tool for analyzing the pathogenesis caused by defects in mitochondrial quality control and for screening candidate drugs for PD. Moreover, dopaminergic neurons could provide new findings not obtained in other cells. In this chapter, we will describe our method for monitoring PINK1-Parkin signaling using iPS cell-derived dopaminergic neurons.
    Keywords:  Autophagy; Dopaminergic neuron; Immunocytochemistry; Mitochondria; PINK1; Parkin; Ubiquitin; Western blot; iPS cells
    DOI:  https://doi.org/10.1007/978-1-0716-5699-0_16
  2. Autophagy. 2026 12;22(12): 3357-3362
      Where is the autophagy field headed? What pathway within the general topic of autophagy is worth studying? Just how many more ATG proteins are there? These are all relevant questions, and it is sometimes difficult to know how to answer them. When facing such doubts I have found it useful time and again to consult with the Motor City.
    Keywords:  Auto-phagy; future directions; insights from Detroit; license plates; macroautophagy; this is what happens when you are the editor-in-chief for too long
    DOI:  https://doi.org/10.1080/15548627.2026.2743935
  3. Proc Natl Acad Sci U S A. 2026 Nov 24. 123(47): e2628364123
      Rubicon is a negative regulator of autophagy and the endolysosomal network (ELN) and an antagonist of the class III phosphatidylinositol 3-kinase complex II (PI3KC3-C2). Inhibition of Rubicon is considered a potential means to therapeutically upregulate autophagy and the ELN to treat Parkinson's disease and other conditions characterized by autophagic and ELN dysfunction. Rubicon is specific for the UV radiation resistance-associated gene protein (UVRAG)-containing PI3KC3-C2 over the purely autophagic ATG14-containing PI3KC3-C1 complex. Here, we determined the high-resolution cryoelectron microscopy structure of PI3KC3-C2 in complex with the PI3KC3-binding domain of Rubicon and compared it to cryo-EM structures of unbound PI3KC3-C2 and PI3KC3-C1. Rubicon binds directly to PI3KC3-C2 only via the BARA domain of the BECN1 subunit, which is common to both C1 and C2. The selectivity of Rubicon for the PI3KC3-C2 complex over the PI3KC3-C1 complex is attributed to a conformation of the BECN1BARA domain induced by UVRAG, rather than to direct contact with UVRAG or direct antagonism by the ATG14 subunit of PI3KC3-C1. Targeted disruption of the Rubicon:PI3K3-C2 structural interface by site-directed mutations enhances mitophagic activity in human epithelial cells to levels comparable to those observed in Rubicon knockout cells. Similarly, disruption of the interaction in Rubicon-overexpressing hippocampal neurons restored lysosomal flux to wild-type levels. These data show that suppressing the function of PI3K3-C2 can fully account for the negative regulatory effects of Rubicon in the autophagy and ELN pathways.
    Keywords:  Parkinson’s disease; autophagy; cryo-EM; lysosome; mitophagy
    DOI:  https://doi.org/10.1073/pnas.2628364123
  4. Autophagy. 2026 Nov 20. 1-3
      Autophagy is largely orchestrated at membranes. Despite the central role of lipids in autophagy, how they regulate protein activity and direct downstream autophagic outcomes remains understudied. MAP1LC3B/LC3B is a core component of the autophagic machinery that binds to LIR-(LC3-interacting region) containing proteins upon membrane association. Using simulations of physiologically relevant structural models of LC3, we identified a discrete allosteric site through which membrane lipids transmit signals to the LIR-binding pocket. Engineering this allosteric site recapitulates the predicted switching behavior, altering LIR recognition, cargo sequestration and downstream autophagic function. Our study, thus, demonstrates that membrane recognition mechanisms in autophagy can be rationally programmed.
    Keywords:  Allostery; protein dynamics; protein engineering; protein-lipid interactions; structural biology
    DOI:  https://doi.org/10.1080/15548627.2026.2763994
  5. Cell Commun Signal. 2026 Aug 19. pii: 629. [Epub ahead of print]24(1):
      Autophagy maintains cellular homeostasis by degrading and recycling intracellular components, while the selective clearance of damaged mitochondria, known as mitophagy, ensures mitochondrial quality control. Protein complexes orchestrate these processes, yet their dynamic regulation remains incompletely understood. Here, we integrate thermal proteome profiling with co-aggregation analysis to monitor protein thermal stability and complex assembly dynamics in response to two canonical inducers: Torin 1, which activates autophagy via mTOR inhibition, and CCCP, a mitochondrial uncoupler that triggers mitophagy. This endeavor provides a global view of the dynamic variations of known autophagy- and mitophagy-associated complexes, revealing their assembly state at various stages. Notably, we identify previously uncharacterized complexes containing the eukaryotic elongation factor 1 A1 (EEF1A1) that exhibit enhanced aggregation under both treatments. Functional analyses show that EEF1A1 depletion impairs autophagosome maturation and mitophagic degradation, while pulsed-SILAC demonstrates that EEF1A1 directly regulates the synthesis of core autophagy proteins. Together, these findings map the dynamic landscape of protein complex regulation during autophagy and mitophagy and uncover EEF1A1-mediated translational control as a previously unrecognized regulatory mechanism.
    Keywords:  Autophagy; EEF1A1; Mitophagy; Protein complex; Thermal proximity co-aggregation; Translation
    DOI:  https://doi.org/10.1186/s12964-026-03152-z
  6. Sci Adv. 2026 Nov 20. 12(47): eaei4136
      Mycobacterium tuberculosis (Mtb) survives in macrophages by interfering with host lysosomal trafficking. Previously, we demonstrated that the Mtb protein, CpsA, is critical for bacterial survival in macrophages and infection in mice and that it can inhibit a noncanonical autophagy pathway. We also found that CpsA can interact with NDP52 and TAX1BP1, selective autophagy receptors that recognize cytosolic bacteria and target them for degradation, raising the possibility that CpsA also disrupts canonical autophagy. Here, we show that CpsA binds NDP52 and TAX1BP1 in their SKICH domains, which normally recruit the autophagy initiation machinery and TBK1. We demonstrate that CpsA prevents phagosomal recruitment of FIP200, a component of the autophagy initiation machinery, and blocks TBK1-dependent phosphorylation of p62, leading to impaired xenophagy. Our findings provide mechanistic insight into how Mtb subverts host defenses, revealing that in addition to blocking noncanonical autophagy, CpsA inhibits the TBK1-p62 axis to block xenophagy.
    DOI:  https://doi.org/10.1126/sciadv.aei4136
  7. Cell Mol Life Sci. 2026 Aug 27. pii: 433. [Epub ahead of print]83(1):
      Spinal cord injury represents a devastating central nervous system trauma frequently leading to permanent neurological deficits. Autophagy, a cellular process for clearing damaged organelles and protein aggregates, is crucial for maintaining intracellular homeostasis. Modulation of autophagy can positively influence the repair and functional recovery of injured neurons. Our data demonstrates that inhibition of spastin disrupts autophagic flux, resulting in the accumulation of autophagosomes. Mechanistically, we found that spastin interacts with ATG5 to facilitate autophagosome formation. Interference with spastin, either through inhibition or knockdown, attenuates this interaction, subsequently impairing the assembly of the ATG12-5-16L1 complex and hindering autophagy initiation. Consequently, intracellular macromolecular debris accumulates, lysosomal function is compromised, and spinal cord injury repair is exacerbated. Collectively, these findings establish a role for the spastin-ATG5 interaction in autophagosome biogenesis and demonstrate that spastin inhibition effectively blocks autophagic flux.
    Keywords:  ATG5; Autophagy; Autophagy flux; Spastin; Spinal cord injury
    DOI:  https://doi.org/10.1007/s00018-026-06414-8
  8. J Cell Biol. 2026 Dec 07. pii: e202411213. [Epub ahead of print]225(12):
      Peroxisomes are dynamic metabolic organelles whose dysfunction results in severe diseases. The homeostasis of peroxisomes is also ensured through pexophagy, a type of selective autophagy targeting these organelles. Pexophagy can be activated by several stressors, such as starvation, mTOR inhibition, and iron deficiency. However, the regulatory mechanisms underlying pexophagy are poorly characterized. Here, we identify a novel regulatory axis of iron deficiency-induced pexophagy, which preferentially engages GABARAP among the mATG8 family members. Comparative analysis of the mATG8 interactomes reveals that upon iron depletion, GABARAP selectively interacts with the tumor suppressor complex FLCN/FNIP1 triggering the activation of the autophagy and lysosome transcription factors TFEB and TFE3, thus promoting efficient cargo degradation. Our findings thus identify the GABARAP-FLCN/FNIP1 axis as a molecular sensor that bridges iron deficiency and TFEB/TFE3 activation to prime pexophagy execution.
    DOI:  https://doi.org/10.1083/jcb.202411213
  9. Cell Commun Signal. 2026 Aug 26. pii: 623. [Epub ahead of print]24(1):
      Autophagy and migrasome formation constitute critical cellular mechanisms for maintaining cellular homeostasis, however, their potential compensatory interplay remains poorly understood. In this study, we identify VPS39-a core component of the HOPS complex-as a molecular switch coordinating these processes. Genetic ablation of VPS39 not only impairs autophagic flux but also triggers cell migration through RhoA/Rac1 GTPases upregulation, consequently facilitating migrasome formation. Using super-resolution microscopy, we further demonstrate that migrasomes serve as an alternative disposal route for damaged mitochondria during VPS39-induced autophagy impairment, revealing a novel stress adaptation mechanism. Our work establishes a previously unrecognized autophagy-migrasome axis and provides direct visual evidence of organelle quality control via migrasomal expulsion. These findings position VPS39-regulated pathway switching as a potential therapeutic strategy for neurodegenerative diseases characterized by autophagy dysfunction.
    Keywords:  Autophagy; Migrasome; Mitochondrial quality control; Stress adaptation; Super-resolution imaging; VPS39
    DOI:  https://doi.org/10.1186/s12964-026-03168-5
  10. EMBO Mol Med. 2026 Nov 17.
      Mitochondria and lysosomes are central regulators of cellular metabolism, nutrient sensing, cellular quality control, and stress adaptation. Although traditionally studied as independent organelles, it is now evident that they operate as an integrated functional network through multiple modes of communication, including membrane contact sites, signaling pathways, and selective vesicular trafficking. Disruption of this crosstalk is increasingly recognized as a common feature of mitochondrial disorders, lysosomal storage diseases, neurodegeneration, cardiovascular disease, and aging, highlighting its importance for cellular and tissue homeostasis. While mitophagy has long been considered the principal interface between mitochondria and lysosomes, recent discoveries have revealed a much broader communication landscape in which bidirectional signaling, ion exchange, lipid transfer, and mitochondria-derived vesicles coordinate organelle function independently of bulk degradation. In this Review, we discuss the molecular mechanisms that mediate mitochondria-lysosome communication, emphasizing emerging concepts in inter-organelle signaling and membrane contact biology. We further examine how disruption of these pathways contributes to human disease and consider the growing evidence that restoring mitochondria-lysosome communication, rather than targeting either organelle in isolation, represents a promising therapeutic strategy.
    DOI:  https://doi.org/10.1038/s44321-026-00556-9
  11. bioRxiv. 2026 Nov 02. pii: 2026.10.30.760220. [Epub ahead of print]
      Lipophagy, the selective degradation of lipid droplets (LDs) by autophagy, has the potential to ameliorate neurodegenerative diseases such as Parkinson's (PD) and Alzheimer's (AD), wherein LD accumulation has been linked to the exacerbation of the proteinopathy component of neurodegeneration. Pharmacological lipophagy inducers remain scarce. We previously identified AA-20 as a novel autophagy activator that acts independently of mTORC1 inhibition, thereby providing a means of stimulating autophagy while avoiding the immunosuppressive side effects associated with direct mTORC1 inhibition. Prior work also showed that AA-20 treatment reduces PolyQ aggregate levels in several C. elegans tissues. Here, we demonstrate that AA-20 enhances LD recruitment to autophagosomes and promotes LD degradation via lysosomal acid lipase activation in murine hippocampal neuronal cells, consistent with lipophagy activation. In human Swedish Amyloid Precursor Protein mutated cerebral organoids, two weeks of AA-20 treatment normalized aberrant lipidomic profiles by selectively reducing various disease-associated lipids, while also correcting the AD-associated electrical hyperexcitability phenotype. Moreover, we identified cyclin-dependent kinase 5 (CDK5), a neuronal kinase linked to AD hyperexcitability and PD pathology, as a target of AA-20. AA-20-induced autophagy and lipid clearance in HT22 cells require CDK5. In a neuronal seeding model of α-synuclein pathology, AA-20 reduced pS129-α-synuclein levels. Collectively, these findings indicate AA-20 can promote lipophagic clearance of LDs and mitigate multiple cellular phenotypes associated with lipidopathy and proteinopathy in neurodegenerative disease models.
    SIGNIFICANCE: Neurodegenerative diseases such as Alzheimer's and Parkinson's are associated with impaired autophagy and abnormal lipid droplet (LD) accumulation. Few small molecules enhance neuronal lipid clearance without inhibiting mTORC1, but chronic blockade of which is associated with immunosuppressive and metabolic side effects. This study shows that AA-20, an mTORC1-independent autophagy activator, promotes lipophagic LD clearance in neuronal cells and reduces selected disease-associated lipids in human Alzheimer's cerebral organoids in a lysosomal acid lipase-dependent manner. AA-20 binds CDK5 and appears to modulate, rather than classically inhibit, this neuron-enriched kinase. In an exploratory Parkinson's neuron model, AA-20 also reduced pathological α-synuclein phosphorylation. These findings support further investigation of AA-20 as a tool to probe neuronal lipid clearance and neurodegeneration-associated phenotypes.
    DOI:  https://doi.org/10.64898/2026.10.30.760220
  12. Int J Biol Macromol. 2026 Nov 16. pii: S0141-8130(26)05274-8. [Epub ahead of print] 155320
      Beyond their roles as substrates for protein synthesis, amino acids serve as potent signaling molecules that convey nutrient availability to the mechanistic target of rapamycin complex 1 (mTORC1), a central regulator of cellular growth, metabolism, and autophagy. This nutrient-dependent regulation relies on a diverse network of sensors distributed across extracellular, cytosolic, and lysosomal compartments. Despite their mechanistic diversity, these pathways converge on the GATOR-Rag GTPase axis to dictate the lysosomal recruitment and activation of mTORC1. Here, we propose a conceptual framework that organizes amino acid sensors according to their subcellular localization, modes of nutrient recognition, and signaling outputs, categorizing them into direct metabolite-binding sensors, stress-responsive sensors, and enzymatic sensors. Drawing on recent structural, biochemical, and physiological insights, this review contrasts how these disparate sensors modulate mTORC1 activity and examines the principles governing multi-nutrient integration. Furthermore, we evaluate the pathological implications of dysregulated amino acid sensing in cancer, metabolic diseases, and neurological and neuropsychiatric disorders. Finally, we highlight recent advances in pharmacologically targeting amino acid-sensing pathways, particularly the modulation of Sestrin-dependent leucine sensing as an emerging strategy for depression.
    Keywords:  Amino acid sensing; CASTOR; Rag GTPase; SAMTOR; Sestrin; mTORC1
    DOI:  https://doi.org/10.1016/j.ijbiomac.2026.155320
  13. Life Sci Alliance. 2027 Feb;pii: e202603914. [Epub ahead of print]10(2):
      The antigen-presenting molecule, MR1, presents microbial metabolites to MAIT cells, a population of innate-like, antimicrobial T cells. It also presents an unidentified ligand to MR1-restricted T cells in the setting of cancer. The cellular cofactors that regulate MR1 antigen presentation have yet to be fully defined. We performed a mass spectrometry-based proteomics screen to identify MR1-interacting proteins and discovered the selective autophagy receptor SQSTM1/p62. CRISPR-Cas9-mediated knockout of SQSTM1/p62 increased MAIT cell activation in the presence of Escherichia coli but not the synthetic ligand 5-OP-RU, whereas depletion of Atg5 and Atg7, key autophagy proteins, increased MAIT activation irrespective of the ligand used. This regulation appears to occur at an early step in the MR1 trafficking pathway. These data implicate distinct roles for autophagy-associated proteins in the regulation of MR1 activity and highlight the contribution of the autophagy pathway to regulation of cellular antigen presentation.
    DOI:  https://doi.org/10.26508/lsa.202603914
  14. Autophagy. 2026 Nov 19.
      Engineered autophagy receptors offer a way to direct intracellular degradation toward proteins implicated in neurodegeneration. Guo and colleagues fused cytoplasm-stable antibody fragments to microtubule-associated protein 1A/1B-light chain 3 alpha (LC3A) and delivered the resulting constructs using small extracellular vesicles. Their experiments show reduced pathological tau and cytoplasmic TAR DNA-binding protein 43 (TDP-43) in neuronal cultures and reduced tau pathology in mice. A separate adeno-associated virus experiment reduces TDP-43 pathology and improves motor performance in mice. These findings connect selective cargo recognition with intracellular delivery and raise questions about how engineered autophagy receptors might be adapted to different disease contexts. Here, we discuss which pathological protein assemblies are most accessible to these receptors, how selective clearance interacts with neuronal autophagic capacity, and how intracellular exposure relates to sustained functional benefit. We consider these questions with particular attention to preserving physiological protein function and linking cargo turnover to neuronal outcomes.
    Keywords:  TDP-43; lysosome; neurodegeneration; selective autophagy; tau
    DOI:  https://doi.org/10.1080/15548627.2026.2767750
  15. Nat Commun. 2026 Nov 20. pii: 11877. [Epub ahead of print]17(1):
      Given the large size of neurons, local maintenance of mitochondria is crucial to counteract insults to this organelle in axons and dendrites. The Parkinson-related mitochondrial kinase PINK1 plays a central role in mitochondrial quality control, which in neurons requires the transport of Pink1 mRNA by mitochondrial hitch-hiking. However, how and where PINK1 is locally translated and processed has remained unclear. Using live-cell imaging, we trace local PINK1 translation sites and preprotein dynamics, revealing a concerted interplay between mitochondria and the ER, with endolysosomes frequently localized adjacent to the site of translation. Upon metabolically regulated untethering from mitochondria, Pink1 mRNA relocates to ribosomes in proximity to the ER and endolysosomes for translation of the PINK1 preprotein. The ER chaperone DNAJB6 shields the PINK1 preprotein in transit to mitochondria, following the post-translational ER-SURF pathway. Consequently, loss of DNAJB6 leads to persistent ER/endolysosome-associated PINK1 precursor stores and failure of mitophagy upon mitochondrial damage. Our findings reveal that neuronal PINK1 protein translation switches between mitochondrially anchored co-translational and ER-associated post-translational import states, with functional implications for mitochondrial quality control.
    DOI:  https://doi.org/10.1038/s41467-026-79754-5
  16. EMBO Mol Med. 2026 Nov 14.
      Mitophagy is critical for maintaining mitochondrial integrity and liver homeostasis, yet the specific microbial signals that regulate this process are poorly defined. Here, we identify bacterial peptidoglycan (PGN), a ubiquitous component of the bacterial cell wall, as a microbial signal that activates hepatocyte mitophagy and protects against liver fibrosis. PGN is internalized by hepatocytes and associates with mitochondria, where it engages the autophagic adaptor p62 (SQSTM1) to promote mitophagy. Hepatocyte-specific loss of p62 completely abolished PGN-induced mitophagy, establishing p62 as an essential mediator of this microbial response. Functionally, PGN-induced mitophagy protected hepatocytes from drug-induced cell death in vitro and in vivo, PGN administration reduced collagen deposition and hepatic stellate cell activation in a CCL4-induced model of liver fibrosis. These findings reveal a direct functional link between a bacterial cell-wall component and hepatocyte mitochondrial quality control, uncovering a previously unrecognized gut microbiota-mitophagy axis. Thus, PGN-mediated activation of hepatocyte mitophagy represents a potential strategy for restoring mitochondrial homeostasis and limiting fibrotic liver injury.
    DOI:  https://doi.org/10.1038/s44321-026-00548-9
  17. ASN Neuro. 2026 ;18(1): 2759459
      Ageing is associated with changes in autophagic-lysosomal quality control, but these changes are not uniform and do not necessarily indicate reduced autophagy. This narrative review uses a clearance-bottleneck framework to examine how defects in pathway capacity, cargo recognition, autophagosome formation, trafficking, or lysosomal degradation may affect the ageing nervous system. It integrates evidence on lysosomal function and biogenesis, nutrient-sensing and transcriptional regulation, macroautophagy, chaperone-mediated autophagy, protein turnover, and organelle quality control. The review considers how these processes intersect with protein aggregation, mitochondrial dysfunction, synaptic regulation, and inflammatory communication among neurons, microglia, and astrocytes. Findings across Alzheimer's disease and tauopathies, Parkinson's disease, amyotrophic lateral sclerosis/frontotemporal dementia, and Huntington's disease/polyglutamine disorders are compared with attention to cargo, cellular context, model, and evidence from human studies. Methodological limitations are emphasized, particularly the inability of autophagy markers alone to establish completed flux. Therapeutic studies are evaluated separately for rescue, human target engagement, and clinical benefit. Evidence does not establish that precision correction of a defined neuronal autophagy defect improves clinical outcomes. The framework identifies priorities for validating clearance defects and testing interventions.
    Keywords:  Ageing; autophagy; lysosomal dysfunction; neurodegeneration
    DOI:  https://doi.org/10.1080/17590914.2026.2759459
  18. Immunol Res. 2026 Nov 19. pii: 147. [Epub ahead of print]74(1):
      Knee osteoarthritis (KOA) is a chronic degenerative disease characterized primarily by chondrocyte senescence. Despite substantial progress in understanding the underlying degenerative pathology in recent years, effective clinical therapeutic strategies for KOA remain urgently needed. Accumulating evidence indicates that mitochondrial damage-manifested by elevated intracellular reactive oxygen species (ROS) and the release of mitochondrial DNA (mtDNA)-is a critical driver of chondrocyte senescence. Mitophagy, a core mechanism of mitochondrial quality control, selectively eliminates damaged and dysfunctional mitochondria, thereby reducing cytoplasmic ROS levels and regulating mtDNA release, ultimately retarding cellular senescence. Therefore, elucidating the molecular mechanisms by which mitophagy is induced to alleviate chondrocyte senescence holds significant therapeutic promise for KOA. Based on a comprehensive review of the literature, we propose the central hypothesis that SIRT6, through deacetylation of Parkin, enhances its E3 ubiquitin ligase activity, thereby activating the PINK1/Parkin pathway‑mediated mitophagy. This promotes the timely clearance of damaged mitochondria and subsequently alleviates chondrocyte senescence. This review suggests that targeting SIRT6 to modulate mitophagy may serve as a critical link between molecular regulation and cellular homeostasis, offering a novel avenue for the clinical prevention and treatment of KOA.
    Keywords:  Chondrocyte senescence; Mitophagy; Osteoarthritis; Reactive oxygen species; Sirt6
    DOI:  https://doi.org/10.1007/s12026-026-09882-z
  19. J Pathol. 2026 Nov 17.
      The intraneuronal accumulation of amyloid-β (Aβ) is an early pathogenic event in Alzheimer's disease (AD), initiating a pathological cascade that includes synaptic dysfunction, metabolic deficits, and eventual neuronal loss. Transcription factor EB (TFEB), a master regulator of the autophagy-lysosomal pathway (ALP) and mitochondrial homeostasis, represents a promising therapeutic target. However, its efficacy and mechanisms when specifically activated in neurons during the prodromal stage remain unclear. Here, we used an adeno-associated virus (AAV) under the control of the CaMKIIα promoter to achieve excitatory neuron-specific TFEB overexpression in the hippocampal CA1 region of 2 months-old 5×FAD mice. This intervention significantly reduced soluble Aβ levels at 3 months and attenuated amyloid plaque burden, dystrophic neurite formation, and glial activation at 6 months, accompanied by substantial improvements in spatial learning and memory. Mechanistically, transcriptomic and functional analyses revealed that TFEB not only enhanced autophagic flux and lysosomal biogenesis but also promoted the expression of key mitochondrial genes and improved mitochondrial function. In APP695swe-N2a cells, TFEB overexpression increased levels of LC3B-II and LAMP1, enhanced mitochondrial activity and biogenesis (via PGC-1α upregulation), and effectively reduced intracellular Aβ accumulation. Our findings demonstrate that targeted TFEB overexpression in excitatory neurons during early AD pathogenesis initiates a protective cascade by co-activating autophagy-lysosomal clearance and mitochondrial pathways, thereby reducing Aβ accumulation and mitigating downstream pathology. This study highlights the potential of neuron-specific TFEB activation as a cell-type-specific therapeutic approach for early AD intervention. © 2026 The Pathological Society of Great Britain and Ireland.
    Keywords:  5×FAD; Alzheimer's disease; TFEB; amyloid‐β; autophagy; excitatory neuron; lysosome; mitochondria
    DOI:  https://doi.org/10.1002/path.70153
  20. J Cell Biol. 2026 Dec 07. pii: e202505037. [Epub ahead of print]225(12):
      Lysosomes are essential for cell survival but are highly susceptible to pathological stressors. Thus, the ability to initiate an acute damage response and promote recovery is critical for maintaining cellular homeostasis. Although studies have advanced understanding of acute responses to lysosomal injury, the mechanisms governing the recovery stage and how this phase differs from the initial injury response remain poorly defined. Here, we identify a distinct response during the recovery stage. We provide the first evidence that recovery from acute damage triggers processing body (PB) formation, membraneless biomolecular condensates. Mechanistically, PBs are selectively induced during recovery, but not during acute damage, through interactions with stress granules (SGs), distinct membraneless biomolecular condensates formed upon acute injury. Functional analyses reveal that PBs promote lysosomal quality and cell survival by collaborating with SGs. Together, these findings establish PBs as central effectors of the lysosomal recovery program and underscore the broader relevance of biomolecular condensates in cellular responses to lysosomal damage and related diseases.
    DOI:  https://doi.org/10.1083/jcb.202505037
  21. Mol Neurobiol. 2026 Nov 19. pii: 1048. [Epub ahead of print]63(1):
      Mitochondrial dysfunction is a defining feature of Parkinson's disease (PD), but it is still often framed as a neuron-autonomous defect of vulnerable dopaminergic neurons. This view misses an intercellular layer of mitochondrial quality control in which glia, extracellular vesicles, tunnelling nanotubes, and mitochondrial extrusion pathways influence whether mitochondrial material is retained, degraded, transferred, or released. In acute CNS injury, mitochondrial transfer can restore bioenergetic capacity in stressed cells. In PD, the same process is unlikely to be uniformly protective. PINK1/Parkin, LRRK2, GBA1, and α-synuclein affect mitochondrial quality control, organelle trafficking, vesicle biology, lysosomal clearance, and innate immune activation. These changes create conditions in which transferred cargo may be beneficial, disposable, or harmful. Here, we distinguish direct PD evidence from mechanisms inferred from other CNS disorders and general cell biology. We interpret mitochondrial transfer in PD through two linked variables: cargo quality and recipient cell state. Functional mitochondria may support metabolic repair; damaged organelles may be routed for disposal; and α-synuclein- or mtDNA-associated cargo may propagate proteopathic stress and inflammation. Therapeutic strategies should therefore focus less on increasing mitochondrial movement per se than on enriching competent cargo, preserving donor cell fitness, and preventing transfer routes from amplifying pathology.
    Keywords:  Extracellular vesicles; Mitochondrial quality control; Mitochondrial transfer; Mitophagy; Neuroinflammation; Parkinson’s disease; Tunnelling nanotubes; α-Synuclein
    DOI:  https://doi.org/10.1007/s12035-026-06355-0
  22. Nat Rev Mol Cell Biol. 2026 Nov 18.
      ERphagy, the lysosomal turnover of endoplasmic reticulum (ER) subdomains, sustains ER function by adapting ER architecture and content to changing cellular demands. It operates constitutively and is enhanced either as one of the cellular programmes triggered by nutrient restriction or during cellular differentiation, or, more selectively, by ER-centric cues such as recovery from ER stress, defective protein translocation in the ER, or the accumulation of misfolded polypeptides in the ER lumen or membrane. In this Review, we discuss how membrane-associated and soluble ERphagy receptors cooperate with chaperones, adaptors, membrane-remodelling factors and core autophagy proteins to select cargo, delimit ER subdomains, separate them from the continuous ER network and coordinate their lysosomal delivery. We cover recent findings on the mechanisms, activation and regulation of ERphagy and of the related ER-to-lysosome-associated degradation pathways, and on their roles in physiology and disease. Finally, we consider therapeutic strategies that target ERphagy to selectively restore ER homeostasis or eliminate harmful ER content.
    DOI:  https://doi.org/10.1038/s41580-026-01051-2
  23. Cell Death Differ. 2026 Nov 17.
      Autophagy is an essential catabolic pathway that safeguards cellular and tissue homeostasis, yet the systemic consequences of its impairment in mammals remain poorly defined because complete autophagy ablation is embryonic or perinatal lethal. Here, we generate ATG4A-only mice, a model in which ATG4A is the sole remaining ATG4 protease due to combined ATG4B/C/D deletion. Through comprehensive biochemical and cellular analyses, we delineate the in vivo substrate specificity of ATG4A and demonstrate that it sustains only minimal ATG8 priming, uncovering a previously unrecognized functional asymmetry within the mammalian ATG4-ATG8 system. ATG4A-only mice exhibit a profound but incomplete whole-body autophagy deficiency that disrupts multiple organ systems and triggers a premature aging syndrome marked by increased DNA damage, systemic senescence, metabolic dysfunction, and dramatically shortened lifespan. Integrating these findings with comparisons to additional ATG4-deficient models, we show that organismal longevity scales with residual autophagic competence. Together, our work reveals how graded reductions in autophagy integrity influence tissue fitness and aging, establishing autophagic capacity as a key determinant of mammalian lifespan.
    DOI:  https://doi.org/10.1038/s41418-026-01934-z
  24. Essays Biochem. 2026 Nov 20. pii: EBC20260040. [Epub ahead of print]
      Nutrient availability is typically treated as an input to the target of rapamycin (TOR) pathway, the conserved controller of growth, metabolism and ageing. Yet, membrane transporters are not merely suppliers of the amino acids and other nutrients that activate TOR, they are integral components of the signalling network itself, and TOR in turn governs their activity, abundance, trafficking and degradation. This bidirectional coupling - including transporters that double as receptors, or 'transceptors' - is mechanistically defined in budding yeast, where the TORC1 complex acts through the Npr1-arrestin axis and vacuolar Gtr/EGO amino acid sensing, conserved in fission yeast, where TOR links nitrogen transport and vacuolar function to growth, stress and lifespan; and elaborated in metazoans across intestinal and fat-body uptake, endocrine relays and lysosomal gatekeepers such as SLC38A9, NPC1 and TRPML1. We propose that TOR-transporter coupling offers a conserved and mechanistically compelling, but still, largely untested, route linking nutrient transport to stress resistance and lifespan across eukaryotes and we advance it as a framework to guide future causal work rather than a settled conclusion.
    Keywords:  Rag GTPases; amino-acid transport; lysosome and vacuole; membrane transporters; nutrient sensing; transceptors
    DOI:  https://doi.org/10.1042/EBC20260040
  25. Cold Spring Harb Perspect Biol. 2026 Nov 19. pii: a041785. [Epub ahead of print]
      Lysosomes are multifunctional organelles that store and release calcium ions (Ca2+), a key second messenger. Two-pore channels (TPCs) and members of the transient receptor potential (TRP) mucolipin (TRPML) subfamily are the principal lysosomal Ca2+ release channels, but how Ca2+ is taken up by lysosomes is less clear. TPCs have emerged as unusual ion channels that are able to dramatically switch their ion selectivity from a Ca2+-permeable state to a more Na+-selective state to differentially control cell-wide Ca2+ signals and lysosomal function in an agonist-selective manner. Long-sought accessory proteins that confer sensitivity of these channels to the Ca2+ mobilizing messenger nicotinic acid adenine dinucleotide phosphate (NAADP) have been identified as JPT2 and Lsm12. Functional roles for TPCs in trafficking both inwardly (phagocytosis) as well as outwardly (hormone/inflammatory mediator secretion and adhesion molecule presentation) have been resolved-roles likely linked to the actions of TPCs at membrane contact sites between the endolysosomal system and the endoplasmic reticulum (ER). Gain-of-function in TPC2 by mutation, or by loss of a negative channel regulation (through TMEM63A), causes pigmentation and pancreatic dysfunction, respectively. Inhibiting TPCs by molecular or chemical means, in particular with tetrandrine (for which analog-bound structures exist), is proving beneficial in models of Alzheimer disease, Parkinson's disease, stroke, and melanoma. Select activation of TPC2 by new "mode-switching" agonists appears to be equally beneficial in correcting lysosomal storage disorders and Parkinson's disease. Like TPCs, TRP mucolipins are activated by the phosphoinositide PI(3,5)P2 More recently discovered endogenous TRP mucolipin activators include pressure and PI(3)P. Also, like TPCs, TRP mucolipins appear functionally coupled to Ca2+ channels on the sarcoplasmic reticulum with a surprising role for TRPML1 in generating ryanodine receptor-dependent subcellular Ca2+ signals underpinning smooth muscle contractility. Insight into regulation of autophagy by TRP mucolipins accrues; we also now know that activation of TRPML1 results in direct Ca2+ transfer from lysosomes to mitochondria at contact sites between the two organelles, and that this communication is disrupted in Mucolipidosis type IV, as well as in models of other neurogenerative diseases. TRP mucolipins are implicated in lung dysfunction and cancer, with the first identification of cancer-causing mutations in TRPML3. TRP mucolipin agonists have now been used successfully to correct phenotypes in a number of disease models, and agonist, as well as antagonist-bound structures, are providing new atomic insight into channel workings. The molecular basis for lysosomal Ca2+ uptake continues to be actively investigated. Candidates include the Ca2+ transporter TMEM165, the mutation of which is known to cause congenital disorders of glycosylation, and pumps such as ATP13A2 and those found typically on the ER.
    DOI:  https://doi.org/10.1101/cshperspect.a041785
  26. Nat Commun. 2026 Oct 21. pii: 11829. [Epub ahead of print]17(1):
      The transcription factor TFE3 coordinates cellular adaptation to stress. While its acute activation is cytoprotective, chronic TFE3 dysregulation is linked to diverse pathologies. Here, we characterize the cellular landscape of TFE3-NDD, a recently described neurodevelopmental disorder caused by mutations that disrupt the TFE3-Rag GTPase interface, leading to constitutive TFE3 nuclear localization. Using patient-derived fibroblasts, we show that TFE3-NDD is primarily a metabolic and homeostatic disorder. Mutant cells undergo a profound rewiring toward oxidative phosphorylation (OXPHOS), resulting in metabolic rigidity and a vulnerability to energy failure. Despite a massive expansion of the lysosomal compartment, we observe a paradoxical qualitative failure characterized by impaired acidification, defective protease maturation, increased lysosomal exocytosis, and aberrant cathepsin K secretion. This secretory phenotype is coupled with a destabilized cell-extracellular matrix interface, marked by impaired migration, defective coordination between actomyosin tension and focal adhesion maturation, and a loss of synaptic stabilizers. Notably, TFE3-NDD shares a signature of high OXPHOS and ferroptosis resistance with TFE3-dependent cancers, such as translocation renal cell carcinoma. Our findings reveal how the chronic hyperactivation of a protective stress-response factor collapses cellular homeostasis, providing a mechanistic framework for the tissue malformations and neurodevelopmental deficits that define TFE3-NDD.
    DOI:  https://doi.org/10.1038/s41467-026-78845-7
  27. Front Cell Dev Biol. 2026 ;14 1992453
      SQSTM1/p62 is a multifunctional selective autophagy receptor and stress-responsive scaffold protein that integrates autophagy, oxidative stress responses, inflammation, and metabolic signaling. Initially characterized as an autophagic adaptor for ubiquitinated cargo, SQSTM1/p62 is now recognized as a central signaling hub that shapes tumor initiation, progression, metastasis, and therapeutic resistance. Its diverse biological activities arise from a modular domain architecture, dynamic post-translational modifications, and context-dependent interactions with key regulators including LC3, KEAP1, TRAF6, and mTORC1-associated components. In cancer, SQSTM1/p62 can exert both tumor-suppressive and tumor-promoting effects, depending on the cellular lineage, stage of tumorigenesis, autophagic competence, subcellular localization, and microenvironmental context. In this review, we summarize the structural basis of SQSTM1/p62 function, the multilayered mechanisms regulating its expression and activity, and the major signaling pathways organized by SQSTM1/p62 in tumor cells and the tumor microenvironment. We further discuss recent progress in pharmacological targeting of SQSTM1/p62 and highlight the challenges of selectively inhibiting oncogenic SQSTM1/p62 signaling without disrupting its essential physiological functions. Collectively, this review positions SQSTM1/p62 as a context-dependent molecular integrator and a promising, yet complex, therapeutic target in cancer.
    Keywords:  SQSTM1/p62; cancer; post-translational modifications; signaling pathway; tumor microenvironment
    DOI:  https://doi.org/10.3389/fcell.2026.1992453